Accelerated single cell seeding in relapsed multiple myeloma
Open Access
- 17 July 2020
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Abstract
Multiple myeloma (MM) progression is characterized by the seeding of cancer cells in different anatomic sites. To characterize this evolutionary process, we interrogated, by whole genome sequencing, 25 samples collected at autopsy from 4 patients with relapsed MM and an additional set of 125 whole exomes collected from 51 patients. Mutational signatures analysis showed how cytotoxic agents introduce hundreds of unique mutations in each surviving cancer cell, detectable by bulk sequencing only in cases of clonal expansion of a single cancer cell bearing the mutational signature. Thus, a unique, single-cell genomic barcode can link chemotherapy exposure to a discrete time window in a patient′s life. We leveraged this concept to show that MM systemic seeding is accelerated at relapse and appears to be driven by the survival and subsequent expansion of a single myeloma cell following treatment with high-dose melphalan therapy and autologous stem cell transplant.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- Moving From Cancer Burden to Cancer Genomics for Smoldering MyelomaJAMA Oncology, 2020
- Genomic patterns of progression in smoldering multiple myelomaNature Communications, 2018
- Genomic complexity of multiple myeloma and its clinical implicationsNature Reviews Clinical Oncology, 2016
- Smoldering multiple myelomaBlood, 2015
- Genetics of multiple myeloma: another heterogeneity level?Blood, 2015
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNature Communications, 2014
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted TherapyCancer Cell, 2014
- Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptomsLeukemia, 2013
- The genetic architecture of multiple myelomaNature Reviews Cancer, 2012